Compare MCHP & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCHP | KVUE |
|---|---|---|
| Founded | 1989 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Specialty Chemicals |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.1B | 39.9B |
| IPO Year | 1993 | 2023 |
| Metric | MCHP | KVUE |
|---|---|---|
| Price | $67.17 | $17.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 13 |
| Target Price | ★ $74.43 | $20.31 |
| AVG Volume (30 Days) | 9.9M | ★ 37.7M |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | 2.71% | ★ 4.79% |
| EPS Growth | N/A | ★ 35.31 |
| EPS | N/A | ★ 0.75 |
| Revenue | $4,212,399,999.00 | ★ $15,006,000,000.00 |
| Revenue This Year | $5.14 | N/A |
| Revenue Next Year | $19.01 | $2.81 |
| P/E Ratio | ★ N/A | $23.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $34.13 | $14.02 |
| 52 Week High | $77.20 | $25.17 |
| Indicator | MCHP | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 65.34 | 60.53 |
| Support Level | $66.23 | $16.70 |
| Resistance Level | $69.56 | $17.59 |
| Average True Range (ATR) | 2.23 | 0.30 |
| MACD | 1.44 | 0.02 |
| Stochastic Oscillator | 86.09 | 68.72 |
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.